Tate & Lyle's allulose syrup patent application claims upheld in Australia

| Filed in:

London, United Kingdom, 18 January 2024: Tate & Lyle PLC (Tate & Lyle), a world leader in ingredient solutions for healthier food and beverages, has received the last of a series of decisions handed down by the Australian Patent Office upholding its allulose syrup patent application claims, which were challenged by several organisations. Tate & Lyle’s intellectual property covers the manufacturing process and use of stabilised allulose syrups. The Australian Patent Office’s decisions further solidify Tate & Lyle’s leadership position in allulose innovation. Tate & Lyle will respond to appeals filed by organisations challenging its Australian patent applications by continuing to defend its position.

Close-up of low-sugar strawberry ice cream and scoop

For many years Tate & Lyle has invested significantly in research, development, sustainable manufacturing, applications, technical service, regulatory approvals and securing intellectual property rights relating to allulose solutions. This investment in research and innovation resulted in Tate & Lyle being the first company to commercialise a stabilised allulose syrup and be granted multiple allulose patents in markets around the world.  

“Our allulose patent portfolio, which includes numerous granted and pending patent applications worldwide, shows our strength in accelerating innovation for sweetener ingredients,” said Abigail Storms, Senior Vice President of Global Platforms, Sweeteners and Fibres at Tate & Lyle. “Securing, protecting and defending our intellectual property is critical to maintaining our innovation leadership.”

DOLCIA PRIMA® LS Allulose Syrup is part of Tate & Lyle’s sweetener portfolio and highly sought after sugar and calorie reduction toolbox that provides formulation solutions for food and beverage manufacturers seeking to meet the rising consumer demand for healthier products. Tate & Lyle is committed to ensuring broad access to and availability of allulose syrup to worldwide consumers by providing innovation, commercialisation, collaboration and licensing opportunities to other companies in the market.  

Allulose is a low-calorie, sweetening ingredient that has an exceptional, sugar-like taste and texture performance in formulations with a fraction of the calories. Originally identified in wheat, it has since been found in certain fruits including figs, raisins and in maple syrup. It is one of many different rare sugars that exist in nature in very small quantities. Allulose provides bulking and sweetness in food and beverage products while reducing calories, and therefore it can be used in practically any application that conventionally employs nutritive and non-nutritive sweeteners. Its versatility, consumer-friendly labelling, sweetness, and appealing texture make it an ideal choice for low-calorie chocolates, gummies, vitamin gummies and dietary supplements, baked goods and more. 

Tate & Lyle looks forward to significantly broadening the use of DOLCIA PRIMA® Allulose and continues to invest in its science and solution capabilities to deliver breakthrough ingredient technologies.  

- Ends -

For more information, please contact:
Alyssa Hufford
Manager – Global External Communications
[email protected]

Click here for our press image gallery

About Tate & Lyle: 
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on LinkedinX (Twitter)Facebook or YouTube